Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanoma
Brummer, Christina, Faerber, Stephanie, Bruss, Christina, Blank, Christian, Lacroix, Ruben, Haferkamp, Sebastian, Herr, Wolfgang, Kreutz, Marina and Renner, Kathrin (2019) Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanoma. Cancer Letters 442, pp. 453-463.Date of publication of this fulltext: 03 Sep 2021 10:05
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Cancer Letters | ||||
| Publisher: | ELSEVIER IRELAND LTD | ||||
|---|---|---|---|---|---|
| Place of Publication: | CLARE | ||||
| Volume: | 442 | ||||
| Page Range: | pp. 453-463 | ||||
| Date | 2019 | ||||
| Institutions | Medicine > Lehrstuhl für Dermatologie und Venerologie Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) Leibniz Institute for Immunotherapy (LIT) | ||||
| Identification Number |
| ||||
| Keywords | MITOCHONDRIAL OXIDATIVE-METABOLISM; BRAF-MUTANT MELANOMA; CONFERS RESISTANCE; DICLOFENAC SODIUM; CELLS; MITF; CANCER; PHARMACOKINETICS; COMBINATION; OUTCOMES; BRAF; Vemurafenib; Glycolysis; MITF; Diclofenac; NSAID | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 49061 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric